Yes — most of the world places no HIV-related restrictions on entry. CDC says people with well-controlled HIV on treatment "should feel comfortable traveling—many thousands do so each year." Still, about 50 countries require HIV testing or restrict entry, stay, or residence, mostly affecting longer stays. Check your destination in the UNAIDS database, and carry medicine in original labeled packaging with extra doses in your carry-on.
The legal landscape: mostly open, with real exceptions
The United States is itself an example of change. UNAIDS reported that travellers living with HIV could freely enter the U.S. as of 4 January 2010, overturning a policy in place since 1987, after the change was announced in October 2009[5]. Most of the world is open: UNAIDS's own accounting found 203 countries, territories and areas with no HIV-related restrictions on entry, stay and residence, while 48 imposed some form of restriction as of June 2019[3]. CDC's current traveler guidance puts the figure at approximately 50 countries that still require HIV testing or restrict entry, stay, or residence based on HIV status[1].
Because those counts shift and CDC itself notes the country list "may change"[1], the only reliable move is to check the live UNAIDS HIV-related travel restrictions database[4] for your specific destination before you book — not a list in an article, including this one.
UNAIDS's position on these laws is unequivocal: there is "no evidence that HIV-related travel restrictions protect public health," they fuel stigma, they may impair access to antiretroviral therapy, and in 2016 UN Member States agreed to eliminate them. UNAIDS also notes that countries which lifted restrictions "have found no need to re-adopt such measures"[3].
What kind of restriction, and how to verify
Two things determine whether a rule touches you: the country, and the length and purpose of your stay. CDC notes that for long-term stays — often more than 90 days, or those requiring a residency or work permit — medical documentation including HIV status may be required, whereas such requirements are uncommon for short business or tourist stays[1].
Restrictions come in tiers. UNAIDS data describe 19 countries and areas that deport non-nationals based on HIV status and also prohibit short- and/or long-term stay, plus 18 that require HIV testing or disclosure for certain entry, study, work or residency permits — a group that includes Australia (for certain professional groups), New Zealand, Israel, Cuba and Kazakhstan[3]. CDC separately publishes a list of countries that may deport a traveler found to have HIV, while noting the list may change and directing readers to online sources for current information[1]. CDC also flags non-legal barriers, such as employer policies or weak confidentiality protections[1].
Verify twice. Check the current entry, stay and residence rules in the UNAIDS travel-restrictions database[4], and — per NIH — contact the U.S. Embassy or Consulate in your destination country to confirm[2].
Your medicine: packing, paperwork, and privacy
CDC's guidance is concrete: carry HIV medications in their original packaging with labels identifying medication, dosing and patient information; bring at least a few extra days' supply; and keep medications and supplies in carry-on luggage whenever possible[1]. Providers should also supply an official letter outlining prescribed medications and any required medical equipment[1]. NIH adds that prescription medicine should be in original packaging labeled with the dosage, your name and your date of birth, and that you can ask your provider for a letter listing medications, generic names and dosing[2].
On privacy, CDC notes that clinicians may document that the regimen is prescribed for a medical condition without specifically stating it is for HIV treatment, to prevent disclosure of a person's HIV status[1]. That matters, because NIH warns that in countries with entry bans you are not required to disclose your status, but "bringing HIV medicine may indicate your HIV status and result in deportation"[2]. Ask your provider for the neutral wording before you travel — it is a routine request.
For longer trips, CDC suggests identifying a place at your destination to access HIV care, increasing a prescription from a 30-day to a 90-day supply in advance, and being aware that some countries limit the quantity of medicine you may import[1].
Time zones, doses, and staying suppressed on the road
Travel is a classic adherence trap, and NIH names it directly: changes in time zone, jet lag, long flights and busy schedules "can keep you from taking your medicine on time," and if you cross time zones "you may need to adjust the time at which you take your HIV medicine"[2]. The right move is to plan the shift with a professional rather than improvising at the gate: ask your health care provider or pharmacist how to time your dosing when traveling, especially for long flights[2].
NIH's practical protections: bring enough medicine for the whole trip plus a few extra days in case of delays, keep it in your carry-on so lost checked baggage does not cost you doses, and if needed, work with your provider to obtain HIV medicines in another location[2].
Food and water precautions travel with you. CDC advises people with HIV to avoid food- and waterborne infections such as Campylobacter, Cryptosporidium, E. coli, Giardia, Listeria, Salmonella and Shigella — through thorough handwashing, boiled, treated or bottled water where sanitation is inadequate, well-cooked hot food, and avoiding unpasteurized dairy — while noting that routine antimicrobial prophylaxis for bacterial enteric illness is not recommended[1]. NIH likewise advises avoiding tap water, ice, and drinks made with unheated tap water where water may be contaminated[2].
The pre-travel visit: vaccines, insurance, and PEP awareness
Book early. CDC advises that travel planning "should begin several months ahead of departure" to allow time for immunizations, which are generally most effective in people who are asymptomatic with undetectable viral loads and restored CD4 counts[1]. CD4 count shapes vaccine choices: inactivated vaccines are generally safe, some live vaccines are recommended at CD4 ≥200 cells/mm³, and live replicating vaccines should not be given in advanced HIV — with MMR, varicella and yellow fever contraindicated below 200. A yellow fever medical waiver is available when vaccination is contraindicated and plans cannot change[1]. CDC also advises assessing malaria and vector-borne risk, since malaria risk and severity are increased in people with HIV, and suggests that people with low CD4 counts — and pregnant people regardless of CD4 — consider delaying travel to malaria-endemic areas[1].
Insurance. NIH warns that health care abroad is usually not covered by standard insurance, including Medicare and Medicaid, and suggests supplemental travel insurance that covers pre-existing conditions like HIV and medical evacuation[2]. CDC likewise recommends reviewing your coverage and carrying insurance cards and claim forms[1].
PEP, before you need it. If you are traveling with an HIV-negative partner or companion, know the window in advance: CDC states that PEP "must be started within 72 hours (3 days) after exposure," is taken daily for 28 days, and is for emergencies only[6]. Seventy-two hours is not long when you are in an unfamiliar health system, so identify where PEP could be obtained at your destination before you go.
Two more items from the guidance. NIH flags local laws and cultural attitudes toward same-sex relations, noting the U.S. Department of State reports more than 60 countries criminalize consensual same-sex relations[2]. And CDC's caution for anyone with poorly controlled or advanced HIV — CD4 under 200, a prior AIDS-defining illness without immune reconstitution, or symptomatic HIV — is to consider delaying travel pending immune reconstitution and viral suppression[1]. That is a timing question, not a permanent one.
Related questions
Will I be turned away at the border because of HIV?
In most countries, no. UNAIDS counted 203 countries, territories and areas with no HIV-related entry, stay or residence restrictions, though CDC notes about 50 still test or restrict — mostly affecting longer stays and work or residency permits. Check your destination in the UNAIDS travel-restrictions database before booking.
Do I have to declare my HIV status?
NIH states that in countries with entry bans you are not required to disclose your status, but carrying HIV medicine may reveal it and could result in deportation. CDC notes that providers can write a medication letter stating the regimen treats a medical condition without naming HIV.
How do I handle doses across time zones?
Plan it before you fly. NIH advises asking your provider or pharmacist how to time dosing when traveling, especially on long flights, since time-zone changes and jet lag can disrupt on-time dosing.
What if my luggage is lost or my trip is delayed?
Pack for it. NIH advises keeping medicine in your carry-on and bringing enough for the trip plus a few extra days. CDC recommends the same extra supply and carry-on storage, and — for longer trips — identifying a place at your destination to access HIV care.
Related from RiseUpToHIV
References & Sources
- CDC Yellow Book — Travelers with HIV. Primary clinical travel guidance: ~50 restricting countries, medication packing and privacy, vaccines, malaria, and insurance. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- NIH HIVinfo — Traveling Safely With HIV. Disclosure, labeled packaging and provider letters, time-zone dosing, water safety, insurance, and local laws. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- UNAIDS — Still Not Welcome: HIV-Related Travel Restrictions (explainer, data as of June 2019). 203 countries with no restrictions vs 48 with restrictions, restriction types, and UNAIDS's position that these laws do not protect public health. ↩ ↩ ↩
- UNAIDS — HIV-Related Travel Restrictions database. Live, searchable database of current entry, stay and residence rules by country. Check this rather than any static list. ↩ ↩
- UNAIDS — Removal of U.S. entry restrictions based on HIV status (4 January 2010). The U.S. lifted its HIV entry ban on 4 January 2010, ending a policy in place since 1987. ↩
- CDC — PEP (Post-Exposure Prophylaxis). PEP must be started within 72 hours of exposure and is taken daily for 28 days; for emergency use only. ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.